Ketorolac Effects on Post-operative Pain and Lumbar Fusion
Recruiting now · Phase 4 · Has a placebo group
Conditions studied: Lumbar Spinal Fusion
In brief
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Key facts
- Study ID
- NCT06513208
- Run by
- University of Maryland St. Joseph Medical Center
- People needed
- 140
- Starts
- 2026-01-01
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2025-12-22
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 18-85 years old (inclusive)
- Elective posterior lumbar instrumented fusion
- One or two level fusion
- Consent to participate in study and willing to adhere to study follow up
- English proficiency
You may not qualify if…
- < 18 or > 85 years old
- History of renal failure, dialysis, or creatinine over 1.50 mg/dl
- Active or recent smoker (active within past 6 months)
- Revision surgery
- Auto/worker compensation
- Active cancer or history of chemotherapy in past 6 months
- Active narcotic use within 3 months of surgery date
- Infection at operative levels
- Any allergies to NSAIDs or Opioids
Where it is running
- University of Maryland St. Joseph Medical Center — Towson, Maryland, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.